Patents by Inventor Peter Hofschneider

Peter Hofschneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Increasing of the resorption of substances via skin and mucous membranes
    Publication number: 20070172516
    Abstract: The invention relates to the increasing of the resorption of substances via skin and mucous membranes. The invention also relates to substances having an increased capability of being resorbed by skin and mucous membranes, and to pharmaceutical compositions containing substances of this type.
    Type: Application
    Filed: September 3, 2003
    Publication date: July 26, 2007
    Applicant: ProCom Biotechnologische Produktions GmbH
    Inventors: Trutz Podschun, Peter Hofschneider, Eberhard Hildt
  • Particles for gene therapy
    Patent number: 7018826
    Abstract: The present invention relates to particles, comprising: a protein envelope with a fusion protein, which comprises a virus protein, a cell permeability-mediating peptide and a heterologous cell-specific binding site; and a nucleic acid present in the protein envelope, which comprises the sequence for a virus-specific packaging signal and a structural gene. The invention further relates to methods for the preparation of such particles and means suitable for this purpose, as well as the use of the particles in gene therapy.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: March 28, 2006
    Assignee: Island Pharmaceuticals Ltd.
    Inventors: Eberhard Hildt, Peter Hofschneider
  • HBV vectors and cells for producing the same
    Patent number: 6623951
    Abstract: This invention relates to an HBV vector in which functional genes of HBV are at least partially deleted. In addition, this invention concerns a process for producing such an HBV vector as well as cells usable for this purpose.
    Type: Grant
    Filed: March 2, 1998
    Date of Patent: September 23, 2003
    Assignee: MondoGen GmbH
    Inventors: Peter Hofschneider, Peter Habenberger, Ludwig Weiss
  • Use of thiol compounds in viral inactivation
    Patent number: 6426370
    Abstract: The invention relates to the use of thiol compounds in viral inactivation in a cell-free environment, especially in the blood, blood plasma, blood serum, conserved blood, blood products, cell culture liquids and nutrient media and to the application of said compounds on the surface of plants and animals. Viral inactivation occurs without requiring cell metabolism.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: July 30, 2002
    Inventor: Peter Hofschneider
  • USE OF THIOL COMPOUNDS IN VIRAL INACTIVATION
    Publication number: 20020040057
    Abstract: The invention relates to the use of thiol compounds in viral inactivation in a cell-free environment, especially in the blood, blood plasma, blood serum, conserved blood, blood products, cell culture liquids and nutrient media and to the application of said compounds on the surface of plants and animals. Viral inactivation occurs without requiring cell metabolism.
    Type: Application
    Filed: April 19, 2000
    Publication date: April 4, 2002
    Inventor: PETER HOFSCHNEIDER